Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Orchestrating serine/threonine phosphorylation and elucidating downstream effects by short linear motifs. | Biochem J | 2022 | 34989786 | PubTator, text mining | PubMed |
| COL17A1 germline variant p.Ser1029Ala and mucosal malignant melanoma: An autopsy study. | Mol Clin Oncol | 2022 | 34987801 | PubTator, text mining | PubMed |
| Y chromosome is moving out of sex determination shadow. | Cell Biosci | 2022 | 34983649 | PubTator, text mining | PubMed |
| Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation. | Oncol Rep | 2022 | 34970697 | PubTator, text mining | PubMed |
| FDI-6 and olaparib synergistically inhibit the growth of pancreatic cancer by repressing BUB1, BRCA1 and CDC25A signaling pathways. | Pharmacol Res | 2022 | 34954029 | PubTator, text mining | PubMed |
| Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3. | Cancer Lett | 2022 | 34923044 | PubTator, text mining | PubMed |
| Interaction of DBC1 with polyoma small T antigen promotes its degradation and negatively regulates tumorigenesis. | J Biol Chem | 2022 | 34921839 | PubTator, text mining | PubMed |
| The Genetic Association Identified Between Intervertebral Disc Degeneration and Associated Risk Factors Based on a Systems Biology Approach. | Spine (Phila Pa 1976) | 2022 | 34919076 | PubTator, text mining | PubMed |
| Discovery of a novel Aurora B inhibitor GSK650394 with potent anticancer and anti-aspergillus fumigatus dual efficacies in vitro. | J Enzyme Inhib Med Chem | 2022 | 34894976 | PubTator, text mining | PubMed |
| Research progress of Bub3 gene in malignant tumors. | Cell Biol Int | 2022 | 34882895 | PubTator, text mining | PubMed |
| Aurora B phosphorylates Bub1 to promote spindle assembly checkpoint signaling. | Curr Biol | 2022 | 34861183 | PubTator, text mining | PubMed |
| Temporal proteomics reveal specific cell cycle oncoprotein downregulation by p97/VCP inhibition. | Cell Chem Biol | 2022 | 34847375 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data. | Exp Ther Med | 2022 | 34815758 | PubTator, text mining | PubMed |
| Identification of Key Pathways and Genes in SARS-CoV-2 Infecting Human Intestines by Bioinformatics Analysis. | Biochem Genet | 2022 | 34787756 | PubTator, text mining | PubMed |
Mitotic phosphorylation of tumor suppressor DAB2IP maintains spindle assembly checkpoint and chromosomal stability through activating PLK1-Mps1 signal pathway and stabilizing mitotic checkpoint complex. | Oncogene | 2022 | 34775484 | PubTator, text mining | PubMed |
| Key signaling networks are dysregulated in patients with the adipose tissue disorder, lipedema. | Int J Obes (Lond) | 2022 | 34764426 | PubTator, text mining | PubMed |
| Low Cell Number Proteomic Analysis Using In-Cell Protease Digests Reveals a Robust Signature for Cell Cycle State Classification. | Mol Cell Proteomics | 2022 | 34742921 | PubTator, text mining | PubMed |
| SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients. | Transl Oncol | 2022 | 34737118 | PubTator, text mining | PubMed |
| Transcriptome and Exome Analyses of Hepatocellular Carcinoma Reveal Patterns to Predict Cancer Recurrence in Liver Transplant Patients. | Hepatol Commun | 2022 | 34725972 | PubTator, text mining | PubMed |
| Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation. | Mol Omics | 2022 | 34709266 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=42